About Cetirizine Dihydrochloride API
Therapeutic CategoryRespiratory
CAS Number
83881-52-1
API Technology
Synthetic
Dose Form
Oral Solids, Liquid, Opthalmic
Dr Reddy's Development Status
Available
Available Regulatory Filing
USDMF, CEP Submitted, Brazil DMF, Korea DMF, Russia DMF
Mechanism of Action
Cetirizine, a metabolite of hydroxyzine, is an antihistamine; its principal effects are mediated via selective inhibition of H1 receptors.
Indication
Indicated for the relief of nasal and non-nasal symptoms associated with seasonal or perennial allergic rhinitis in adults and children 12 years of age and older.
Related APIs
Cetirizine Dihydrochloride
Respiratory
Desloratadine
Respiratory
Levocetirizine Dihydrochloride
Respiratory
Montelukast Sodium
Respiratory
Request for Quotation
Get in touch with us by filling out the form below. Our team will reach out to you shortly!
FAQs
Treats symptoms of allergic rhinitis and chronic idiopathic urticaria
-
Available as oral tablets (5 mg, 10 mg), chewable tablets (5 mg, 10 mg), and oral solution (1 mg/mL)
-
Store at 20°C to 25°C (68°F to 77°F), in a cool, dry place, away from light and moisture
Disclaimer
No information on this website, including any reference to any product or service constitutes an offer for sale or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, in certain cases, at Dr. Reddy's sole discretion, and subject to local legal requirement, the research quantities of such products may be offered for the purpose of regulatory submissions under Section 107A of the Indian Patent Act (Bolar exemption), wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the product or service including, patent scenario in their respective markets and will be responsible for all patent related liabilities Dr. Reddy's disclaims all warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose and non-infringement.